Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 2:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 1,441 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Measurement Clear all

Conditions: Hydrocephalus
Interventions: FlowSense; Device
Lead sponsor: Rhaeos, Inc.; Industry
Eligibility: Not listed
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 3
States / cities: Tampa, Florida • Chicago, Illinois • Rolling Meadows, Illinois

Conditions: Survivors of Childhood Cancer, Substance Use
Interventions: WHO ASSIST v3.1 Screening with Feedback, ASSIST Linked Brief Intervention (10 Step Motivational interviewing (MI)/FRAMES), WHO ASSIST v3.1 Screening (No Feedback); Behavioral
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 15 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Pleural Effusions
Interventions: Not listed
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Limb-Girdle Muscular Dystrophy ; Subtypes 2A, 2B, and 2I
Interventions: Not listed
Lead sponsor: The Emmes Company, LLC; Industry
Eligibility: 14 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Kingston, Massachusetts

Conditions: Pregnancy, Anesthesia
Interventions: Supine position, Right lateral position, Left lateral position; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Anterior Segment of Eye, Axial Length, Biometrics Measurement
Interventions: UNITY DX, ANTERION; Device
Lead sponsor: Alcon Research; Industry
Eligibility: 21 Years and older
Enrollment: 50 participants
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
Interventions: Sirolimus, Mitoxantrone, Etoposide, Cytarabine; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: ALS
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: Not listed
Enrollment: 397 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Adenoma Detection Rate, Colonoscopy
Interventions: Comparison of ADR; Other
Lead sponsor: Evergreen General Hospital, Taiwan; Other
Eligibility: 50 Years to 80 Years
Enrollment: 2,707 participants
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: North Hills, California

Conditions: Breast Cancer
Interventions: F-18 Fluoroestradiol, Computed Tomography, Positron Emission Tomography, Laboratory Biomarker Analysis; Drug · Procedure · Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Validate Volumetric Absorptive Microsampling (VAMS) Assay
Interventions: Mitra Microsampler; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Year to 21 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Venous Thrombo-embolism
Interventions: Not listed
Lead sponsor: American Venous Forum; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 27
States / cities: Denver, Colorado • Gainesville, Florida • St. Petersburg, Florida + 24 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Insulin Icodec; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 20
States / cities: Palm Springs, California • Sacramento, California • San Diego, California + 15 more

Conditions: Major Depressive Disorder (MDD), fNIRS
Interventions: fNIRS measurement; Other
Lead sponsor: Kernel; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: Los Angeles, California • Sunnyvale, California

Conditions: Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism, Arterial Embolism
Interventions: Coronary and peripheral stents, Pacing catheters, Vascular plugs, Measurement and imaging (FFR and OCT), Peripheral dilatation catheters, Coronary dilatation catheters, Coronary and peripheral guidewires, Vessel closure/compression devices, Vascular access introducers; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 3,784 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2031
U.S. locations: 7
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 4 more

Conditions: Type 2 Diabetes Mellitus, Obesity
Interventions: Roux-en-Y Gastric Bypass Surgery, Laparoscopic Adjustable Gastric Banding, Lifestyle Weight Loss Intervention; Procedure · Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 25 Years to 55 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Metastatic Prostate Cancer
Interventions: Bevacizumab, Lenalidomide, Docetaxel, Prednisone; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Intracranial Pathology, Intracranial Hypertension
Interventions: Phase contrast magnetic resonance imaging; Procedure
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 99 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Miami, Florida

Conditions: Charcot Marie Tooth Disease, Inherited Peripheral Neuropathy
Interventions: Not listed
Lead sponsor: University of Iowa; Other
Eligibility: 10 Years and older
Enrollment: 563 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: Iowa City, Iowa • Rochester, New York

Conditions: Hip Osteoarthritis
Interventions: Not listed
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 60 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Provoked, Localized Vulvodynia, Provoked Vestibulodynia, Vulvar Vestibulitis, Vulvodynia
Interventions: Classical Acupuncture, Non-classical acupuncture, Lidocaine; Procedure · Drug
Lead sponsor: Oregon College of Oriental Medicine; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Breast Cancer
Interventions: Imaging with S-FLARE imaging system; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Measure Grams and Kcals of Snack Foods Consumed in Each Condition
Interventions: Healthy Foods, Unhealthy Snack Foods; Other
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 18 Years to 30 Years · Female only
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Physical Examination, Ultrasound Imaging, Abdominal Aortic Aneurysm
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Flow Measurements in Functional CSF Shunts and Off-Shunt Locations with a Second-Generation Thermal Device

Feasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors

iSTAT Comparison Study, IRB3785

Limb-Girdle Video Assessment

Measurement of Hemodynamic Variables Under Spinal Anesthesia With Varied Positioning

Agreement of Two OCT Biometers: A Pilot Study

Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia

Exposure to Neurotoxins as Risk Factors for ALS

Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Tacrolimus Microsampling

National Inferior Vena Cava (IVC) Filter Registry

A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)

Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements

Abbott Vascular Medical Device Registry

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer

Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure

Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)

Ultrasound and CT to Measure Muscle in Hip OA

Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study

Tissue Oxygenation Measurements With Modulated Light (S-FLARE)

The Effect of Watching a Television Show on the Liking of Snack Foods

Abdominal Aorta Palpation With Point of Care Ultrasound Imaging Measurements